Lipella Pharmaceuticals Inc. announced that the FDA has approved an Expanded Access Program for LP-310, an oral rinse formulated to treat oral lichen planus (OLP), a debilitating condition affecting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback